Deancy Okoebor

Director of Clinical Operations

Role: Clinical Trial Manager at Diakonos Oncology
Location: Dallas-Fort Worth, TX, US
LinkedIn followers: 500 followers

OperationsView LinkedIn profile

About Deancy Okoebor

Experienced Clinical Research Associate with a demonstrated history of working in the…

Experience

Clinical Trial Manager
Diakonos Oncology
Aug 2017 — Present

Education

Strayer University
MHSA
2012 — 2016
The University of Tennessee at Chattanooga
Bachelor of Science (B.S.)
2004 — 2008

Skills

Good Clinical Practice (Gcp)
Oncology
Protocol
Pharmaceutical Industry
Sop
Clinical Monitoring
Clinical Trial Management System (Ctms)
21 Cfr Part 11
Clinical Research
Gcp
Edc
Data Management
Ctms
Phase I
Ich-Gcp
Oncology Clinical Research
Clinical Trials
Healthcare
CRO
Microsoft Office
Clinical Development
Medidata
Inform
Clinical Data Management
Oracle Clinical

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@diakonosoncology.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Diakonos Oncology

Pharmaceutical Manufacturing · 23 employees · Founded 2016 · Houston, Texas, United States

Diakonos Oncology is a clinical-stage immuno-oncology company advancing DOC1021, a first-in-class autologous dendritic cell immunotherapy designed for aggressive, treatment-resistant solid tumors. Unlike legacy dendritic cell approaches, DOC1021 is a tumor-informed, double-loaded platform that trains the immune system using a patient’s own tumor biology. By presenting both tumor lysate and tumor mRNA, the therapy is designed to activate a broader, more durable immune response against heterogeneous solid tumors. In glioblastoma, early clinical data demonstrated a 88% 12-month survival rate and a favorable safety profile. DOC1021 has received multiple FDA Fast Track designations and is currently being evaluated in clinical trials for glioblastoma, pancreatic cancer, and refractory melanoma at leading U.S. treatment centers. Diakonos has raised approximately $40M to date, including a $7.1M award from CPRIT supporting ongoing development. Our mission is to unlock the full potential of the immune system in cancers where durable options remain limited.

diakonosoncology.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Deancy Okoebor

Experience

Clinical Trial Manager

Education

Strayer University

The University of Tennessee at Chattanooga

Skills

Find verified contacts for anyone on LinkedIn